The CTC conducts collaborative clinical trials research with the Australasian Lung Cancer Trials Group (ALTG). ALTG is a multidisciplinary organisation dedicated to reducing the incidence, morbidity and mortality of lung and thoracic cancer and improving the quality of life of lung and thoracic cancer patients in Australia and New Zealand.

The CTC and the ALTG are currently recruiting patients to trials of new therapies in lung cancer (BR.31, BR.34, and OSCILLATE) and mesothelioma (DREAM), as well as a trial of radiotherapy and antibody therapy for advanced lung cancer (NIVORAD) and early referral to palliative care in patients with a recent diagnosis of advanced thoracic cancer (PEARL).

Lung Cancers